<p>AdaptHealth Corp.（納斯達克代碼：AHCO - 獲取免費報告）週一的午盤交易中，股價下跌了 5.5%。該股最低交易價為 9.90 美元，最後交易價為 9.92 美元。午盤交易中大約交易了 454,654 股，較日均交易量 1,044,496 股下降了 56%。該股此前收盤價為 10.50 美元。</p>
<h2>分析師評級調整</h2>
<ul>
<li>3 只小型股領軍者有望實現顯著增長</li>
</ul>
<p>另外，加拿大皇家銀行在 8 月 12 日的研究報告中重申了對 AdaptHealth 的 “跑贏大盤” 評級，並給出了 13.00 美元的目標價。一位研究分析師對該股給予了賣出評級，一位給予了持有評級，三位給予了買入評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “持有”，平均目標價為 10.70 美元。</p>
<p><strong>查看我們對 AHCO 的最新股票分析</strong></p>
<h2>AdaptHealth 股價下跌 3.3%</h2>
<p>該公司的流動比率為 1.15，速動比率為 0.94，債務與股本比率為 1.38。該股的 50 日移動平均價格為 10.80 美元，200 日移動平均價格為 10.44 美元。該公司的市值為 13.6 億美元，市盈率為-2.01，市盈增長比率為 1.60，貝塔係數為 1.11。</p>
<p>AdaptHealth（納斯達克代碼：AHCO - 獲取免費報告）最近一次發佈季度財報是在 8 月 6 日。該公司報告本季度每股收益（EPS）為 0.13 美元，低於市場共識預期的 0.19 美元（差額為 0.06 美元）。AdaptHealth 的淨利潤率為-21.20%，股本回報率為 9.58%。該公司本季度的收入為 8.0598 億美元，而分析師預期為 8.0262 億美元。去年同期，該公司每股收益為 0.16 美元。該公司的季度收入同比增長了 1.6%。股票研究分析師預測，AdaptHealth Corp.本年度將發佈 0.87 美元的每股收益。</p>
<h2>內部人士下注</h2>
<p>在其他 AdaptHealth 的新聞中，董事 David Solomon Williams III 在 8 月 29 日的交易中出售了 4,000 股該股票。股票以平均價格 11.26 美元出售，總交易額為 45,040.00 美元。交易完成後，該董事現在持有 36,899 股公司股票，價值 415,482.74 美元。這代表其持股比例下降了 0.00%。該交易在向 SEC 的備案中披露，相關信息可在 SEC 網站上找到。在其他 AdaptHealth 的新聞中，首席運營官 Shaw Rietkerk 在 9 月 20 日的交易中出售了 25,000 股該股票。該股票以平均價格 11.24 美元出售，總價值為 281,000.00 美元。交易完成後，首席運營官現在持有 212,611 股公司股票，價值約為 2,389,747.64 美元。該交易代表其持股比例下降了 0.00%。該交易在向 SEC 的備案中披露，相關信息可在 SEC 網站上找到。此外，董事 David Solomon Williams III 在 8 月 29 日的交易中再次出售了 4,000 股公司股票。股票以平均價格 11.26 美元出售，總價值為 45,040.00 美元。交易完成後，該董事現在持有 36,899 股公司股票，價值約為 415,482.74 美元。這代表其持股比例下降了 0.00%。該交易的披露信息可在此處找到。內部人士持有公司 4.43% 的股份。</p>
<h2>機構資金流入和流出</h2>
<p>最近，一些對沖基金增加或減少了對 AHCO 的持股。Covestor Ltd 在第一季度將其在 AdaptHealth 的持股增加了 279.6%。Covestor Ltd 現在持有 3,109 股公司股票，價值 36,000 美元，此前在該期間內又增持了 2,290 股。加拿大養老金計劃投資委員會在第二季度購買了 AdaptHealth 的新頭寸，價值 58,000 美元。Blue Trust Inc.在第二季度購買了 AdaptHealth 的新頭寸，價值 85,000 美元。Innealta Capital LLC 在第二季度購買了 AdaptHealth 的新頭寸，價值 101,000 美元。最後，Quest Partners LLC 在第二季度將其在 AdaptHealth 的持股增加了 11,522.7%。Quest Partners LLC 現在持有 10,228 股公司股票，價值 102,000 美元，此前在該期間內又增持了 10,140 股。82.67% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>關於 AdaptHealth</h2>
<p>（獲取免費報告）</p>
<p>AdaptHealth Corp.及其子公司在美國銷售家庭醫療設備（HME）、醫療用品以及家庭和相關服務。該公司提供睡眠治療設備、用品及相關服務，如為患有阻塞性睡眠呼吸暫停的個人提供 CPAP 和 bi-PAP 服務；醫療設備和用品，包括用於糖尿病治療的連續血糖監測儀和胰島素泵；向從急性護理和其他設施出院的患者提供 HME；在家中提供氧氣和相關慢性治療服務；以及代表慢性病患者提供的其他 HME 設備和用品，包括傷口護理、泌尿、失禁、造口和營養供應需求。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們更看好的股票，勝過 AdaptHealth</li>
<li>3 只可以幫助應對通貨膨脹的食品雜貨股票</li>
<li>英特爾：現在是勇敢出手的時候嗎？</li>
<li>如何投資藍籌股</li>
<li>嘉年華還是皇家加勒比——哪隻郵輪股票更具上漲潛力？</li>
<li>零售投資者如何交易多倫多證券交易所（TSX）？</li>
<li>Summit Therapeutics：他們的肺癌藥物是遊戲規則改變者嗎？</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前經過 MarketBeat 編輯團隊的審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com.</em></p>
<p>→ DeFi Coin 即將突破！(來自 Crypto 101 Media)(廣告)</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDMyOA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDMyOA"/></p>
<h2>你現在應該投資$1,000 在 AdaptHealth 嗎？</h2>
<p>在考慮 AdaptHealth 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 AdaptHealth 並不在名單上。</p>
<p>雖然 AdaptHealth 目前在分析師中被評為 “持有”，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

AHCO

<p>AdaptHealth Corp.（納斯達克代碼：AHCO）股價在午盤交易中下跌了 5.5%，至 0.92 美元，交易量較平均水平下降了 56%。該公司報告的季度每股收益（EPS）為 0.13 美元，未達到預期，淨利潤率為負 21.20%。分析師維持 “持有” 的共識評級，平均目標價為 0.70 美元。近期內部人士的交易包括董事 David Solomon Williams III 出售了 4,000 股，首席運營官 Shaw Rietkerk 出售了 25,000 股。對沖基金持有該股票的 82.67%，顯示出顯著的機構投資興趣</p>

<p>AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report)'s stock price dropped 5.5% during mid-day trading on Monday . The stock traded as low as $9.90 and last traded at $9.92. Approximately 454,654 shares were traded during mid-day trading, a decline of 56% from the average daily volume of 1,044,496 shares. The stock had previously closed at $10.50.</p>
<div class="lb-trans"><p>AdaptHealth Corp.（納斯達克代碼：AHCO - 獲取免費報告）週一的午盤交易中，股價下跌了 5.5%。該股最低交易價為 9.90 美元，最後交易價為 9.92 美元。午盤交易中大約交易了 454,654 股，較日均交易量 1,044,496 股下降了 56%。該股此前收盤價為 10.50 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級調整</h2>
</div><ul>
<li>3 Small-Cap Leaders Poised for Significant Growth</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只小型股領軍者有望實現顯著增長</li>
</ul>
</div><p>Separately, Royal Bank of Canada reissued an &#34;outperform&#34; rating and issued a $13.00 target price on shares of AdaptHealth in a research note on Monday, August 12th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of &#34;Hold&#34; and an average target price of $10.70.</p>
<div class="lb-trans"><p>另外，加拿大皇家銀行在 8 月 12 日的研究報告中重申了對 AdaptHealth 的 “跑贏大盤” 評級，並給出了 13.00 美元的目標價。一位研究分析師對該股給予了賣出評級，一位給予了持有評級，三位給予了買入評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “持有”，平均目標價為 10.70 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on AHCO</strong></p>
<div class="lb-trans"><p><strong>查看我們對 AHCO 的最新股票分析</strong></p>
</div><h2>AdaptHealth Trading Down 3.3 %</h2>
<div class="lb-trans"><h2>AdaptHealth 股價下跌 3.3%</h2>
</div><p>The company has a current ratio of 1.15, a quick ratio of 0.94 and a debt-to-equity ratio of 1.38. The stock's fifty day moving average price is $10.80 and its two-hundred day moving average price is $10.44. The stock has a market capitalization of $1.36 billion, a P/E ratio of -2.01, a price-to-earnings-growth ratio of 1.60 and a beta of 1.11.</p>
<div class="lb-trans"><p>該公司的流動比率為 1.15，速動比率為 0.94，債務與股本比率為 1.38。該股的 50 日移動平均價格為 10.80 美元，200 日移動平均價格為 10.44 美元。該公司的市值為 13.6 億美元，市盈率為-2.01，市盈增長比率為 1.60，貝塔係數為 1.11。</p>
</div><p>AdaptHealth (NASDAQ:AHCO - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). AdaptHealth had a negative net margin of 21.20% and a positive return on equity of 9.58%. The business had revenue of $805.98 million for the quarter, compared to analysts' expectations of $802.62 million. During the same quarter in the previous year, the company earned $0.16 earnings per share. The business's quarterly revenue was up 1.6% on a year-over-year basis. Equities research analysts forecast that AdaptHealth Corp. will post 0.87 EPS for the current year.</p>
<div class="lb-trans"><p>AdaptHealth（納斯達克代碼：AHCO - 獲取免費報告）最近一次發佈季度財報是在 8 月 6 日。該公司報告本季度每股收益（EPS）為 0.13 美元，低於市場共識預期的 0.19 美元（差額為 0.06 美元）。AdaptHealth 的淨利潤率為-21.20%，股本回報率為 9.58%。該公司本季度的收入為 8.0598 億美元，而分析師預期為 8.0262 億美元。去年同期，該公司每股收益為 0.16 美元。該公司的季度收入同比增長了 1.6%。股票研究分析師預測，AdaptHealth Corp.本年度將發佈 0.87 美元的每股收益。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><p>In other AdaptHealth news, Director David Solomon Williams III sold 4,000 shares of the stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $11.26, for a total transaction of $45,040.00. Following the completion of the sale, the director now owns 36,899 shares of the company's stock, valued at $415,482.74. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other AdaptHealth news, COO Shaw Rietkerk sold 25,000 shares of the stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $11.24, for a total value of $281,000.00. Following the completion of the sale, the chief operating officer now owns 212,611 shares in the company, valued at approximately $2,389,747.64. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director David Solomon Williams III sold 4,000 shares of the company's stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $11.26, for a total value of $45,040.00. Following the transaction, the director now owns 36,899 shares of the company's stock, valued at approximately $415,482.74. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.43% of the company's stock.</p>
<div class="lb-trans"><p>在其他 AdaptHealth 的新聞中，董事 David Solomon Williams III 在 8 月 29 日的交易中出售了 4,000 股該股票。股票以平均價格 11.26 美元出售，總交易額為 45,040.00 美元。交易完成後，該董事現在持有 36,899 股公司股票，價值 415,482.74 美元。這代表其持股比例下降了 0.00%。該交易在向 SEC 的備案中披露，相關信息可在 SEC 網站上找到。在其他 AdaptHealth 的新聞中，首席運營官 Shaw Rietkerk 在 9 月 20 日的交易中出售了 25,000 股該股票。該股票以平均價格 11.24 美元出售，總價值為 281,000.00 美元。交易完成後，首席運營官現在持有 212,611 股公司股票，價值約為 2,389,747.64 美元。該交易代表其持股比例下降了 0.00%。該交易在向 SEC 的備案中披露，相關信息可在 SEC 網站上找到。此外，董事 David Solomon Williams III 在 8 月 29 日的交易中再次出售了 4,000 股公司股票。股票以平均價格 11.26 美元出售，總價值為 45,040.00 美元。交易完成後，該董事現在持有 36,899 股公司股票，價值約為 415,482.74 美元。這代表其持股比例下降了 0.00%。該交易的披露信息可在此處找到。內部人士持有公司 4.43% 的股份。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>A number of hedge funds have recently added to or reduced their stakes in AHCO. Covestor Ltd grew its holdings in shares of AdaptHealth by 279.6% during the 1st quarter. Covestor Ltd now owns 3,109 shares of the company's stock worth $36,000 after acquiring an additional 2,290 shares during the period. Canada Pension Plan Investment Board bought a new position in AdaptHealth in the second quarter worth $58,000. Blue Trust Inc. purchased a new position in AdaptHealth during the second quarter valued at $85,000. Innealta Capital LLC purchased a new position in AdaptHealth during the second quarter valued at $101,000. Finally, Quest Partners LLC grew its position in shares of AdaptHealth by 11,522.7% in the 2nd quarter. Quest Partners LLC now owns 10,228 shares of the company's stock worth $102,000 after buying an additional 10,140 shares during the period. 82.67% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>最近，一些對沖基金增加或減少了對 AHCO 的持股。Covestor Ltd 在第一季度將其在 AdaptHealth 的持股增加了 279.6%。Covestor Ltd 現在持有 3,109 股公司股票，價值 36,000 美元，此前在該期間內又增持了 2,290 股。加拿大養老金計劃投資委員會在第二季度購買了 AdaptHealth 的新頭寸，價值 58,000 美元。Blue Trust Inc.在第二季度購買了 AdaptHealth 的新頭寸，價值 85,000 美元。Innealta Capital LLC 在第二季度購買了 AdaptHealth 的新頭寸，價值 101,000 美元。最後，Quest Partners LLC 在第二季度將其在 AdaptHealth 的持股增加了 11,522.7%。Quest Partners LLC 現在持有 10,228 股公司股票，價值 102,000 美元，此前在該期間內又增持了 10,140 股。82.67% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>About AdaptHealth</h2>
<div class="lb-trans"><h2>關於 AdaptHealth</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.</p>
<div class="lb-trans"><p>AdaptHealth Corp.及其子公司在美國銷售家庭醫療設備（HME）、醫療用品以及家庭和相關服務。該公司提供睡眠治療設備、用品及相關服務，如為患有阻塞性睡眠呼吸暫停的個人提供 CPAP 和 bi-PAP 服務；醫療設備和用品，包括用於糖尿病治療的連續血糖監測儀和胰島素泵；向從急性護理和其他設施出院的患者提供 HME；在家中提供氧氣和相關慢性治療服務；以及代表慢性病患者提供的其他 HME 設備和用品，包括傷口護理、泌尿、失禁、造口和營養供應需求。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than AdaptHealth</li>
<li>3 Grocery Stocks That Can Help Take a Bite Out of Inflation</li>
<li>Intel: Is Now the Time to Be Brave?</li>
<li>How to Invest in Blue Chip Stocks</li>
<li>Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?</li>
<li>How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?</li>
<li>Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 AdaptHealth</li>
<li>3 只可以幫助應對通貨膨脹的食品雜貨股票</li>
<li>英特爾：現在是勇敢出手的時候嗎？</li>
<li>如何投資藍籌股</li>
<li>嘉年華還是皇家加勒比——哪隻郵輪股票更具上漲潛力？</li>
<li>零售投資者如何交易多倫多證券交易所（TSX）？</li>
<li>Summit Therapeutics：他們的肺癌藥物是遊戲規則改變者嗎？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前經過 MarketBeat 編輯團隊的審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com.</em></p>
</div><p>→ DeFi Coin on Verge of Breakout! (From Crypto 101 Media)(Ad)</p>
<div class="lb-trans"><p>→ DeFi Coin 即將突破！(來自 Crypto 101 Media)(廣告)</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDMyOA" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10328&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in AdaptHealth right now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 AdaptHealth 嗎？</h2>
</div><p>Before you consider AdaptHealth, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 AdaptHealth 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 AdaptHealth 並不在名單上。</p>
</div><p>While AdaptHealth currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 AdaptHealth 目前在分析師中被評為 “持有”，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

AdaptHealth（納斯達克股票代碼：AHCO）股價下跌 5.5% - 事情是這樣的